Atticus Wealth Management »

Neurogene shares owned by Atticus Wealth Management

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Atticus Wealth Management from 13F filings

Historical chart of Atticus Wealth Management investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Atticus Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Atticus Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $18k 437 41.96

More positions owned by Atticus Wealth Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Neos Etf Trust Neos Enh Inc 1-3 (CSHI)
Hartford Fds Exchange Traded Total Rtrn Etf (HTRB)
Apple (AAPL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr S&p 100 Etf (OEF)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Coca-Cola Company (KO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Innovator Etfs Trust Us Eqty Pwr Buf (PMAY)
Spdr Gold Tr Gold Shs (GLD)
Select Sector Spdr Tr Technology (XLK)

View all positions for Atticus Wealth Management

Top funds holding Neurogene

BlackRock
BlackRock
EcoR1 Capital
Samsara BioCapital
Dr. Jeffrey R. Jay, M.D.
Redmile Group
Henderson Group
Vanguard Group
Casdin Capital
Baker Bros. Advisors
Avidity Partners Management
Arrowpoint Asset Management
Morgan Stanley
Deutsche Bank Aktiengesellschaft
Geode Capital Management

View all funds holding Neurogene